help button home button Endocrine Society JCEM
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

Journal of Clinical Endocrinology & Metabolism Vol. 68, No. 1 9-16
doi:10.1210/jcem-68-1-9
Copyright © 1989 by the Endocrine Society.
This Article
Right arrow Full Text (PDF)
Right arrow Submit a related Letter to the Editor
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by SOTSKY, M. J.
Right arrow Articles by SHAMOON, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by SOTSKY, M. J.
Right arrow Articles by SHAMOON, H.

Regulation of Counterregulatory Hormone Secretion in Man During Exercise and Hypoglycemia*

MINDY J. SOTSKY, SHMUEL SHILO{dagger} and HARRY SHAMOON

Department of Medicine and the Diabetes Research and Training Center, Albert Einstein College of Medicine Bronx, New York 10461

Address all correspondence and requests for reprints to: Dr. Harry Shamoon, Department of Medicine, Albert Einstein College of Medicine, 1300 Morris Park Avenue, Bronx, New York, 10461.

We examined the role of the plasma glucose concentration per se in the secretion of counterregulatory hormones during exercise. Ten men (average age, 24 yr; maximal aerobic capacity, 31.8 mL/kg-min) were studied during two 50- min bicycle exercise periods at either normal glucose [87 ± 1 (± SE) mg/dL (4.8 ±0.1 mmol/L)] or low glucose [59± 1 mg/dL (3.3 ± 0.1 mmol/L)]. The plasma glucose targets were achieved by exogenous insulin and variable glucose infusions. These results were compared to studies in which saline was infused. Exercise at normal glucose was associated with significant increments in plasma epinephrine (maximum 3- to 5-fold above baseline) and norepinephrine (2-fold), comparable to those that occurred during saline administration. Plasma GH increased only at the most intense exercise level, while plasma cortisol and glucagon did not increase significantly. In low glucose-exercise studies, the increase in plasma epinephrine during exercise was significantly greater than that at normal glucose (P <0.01), although proportional to basal preexercise levels (r = 0.73;P < 0.001). Plasma glucagon increased almost 100%, and plasma cortisol and GH increased by 150% and 400%, respectively.Compared to the effect of the same degree of hypoglycemia in the absence of exercise, only plasma epinephrine (P = 0.002) and norepinephrine (P < 0.001) displayed effects independent of hypoglycemia during exercise. When low glucose was reversed to normal at the midpoint of exercise, plasma epinephrine and glucagon returned to the levels obtained for the same duration of exercise at normal glucose, while norepinephrine, GH, and cortisol were only partially responsive to the rise in plasma glucose. These data suggest that 1) moderate exercise is a stimulus for a sympathoadrenal and GH response, but not a peripheral glucagon response; 2) during exercise and hypoglycemia, plasma epinephrine and norepinephrine are enhanced, while the glucagon response is entirely glucose dependent; and 3) the epinephrine response to hypoglycemia can be dissociated from that to exercise, suggesting differing control mechanisms. We conclude that the activation of counterregulatory hormones during exercise is regulated by glucose-independent mechanisms, although these responses may be augmented by concurrent hypoglycemia.

* This work was supported by Grants 5RO1-DK-36617 (to H.S. and S.S.), Training Grant DK-07004 (to M.J.S.), the Diabetes Research and Training Center Core Radioimmunoassay Laboratory (5P60-DK- 20541), and Clinical Research Center Grant RR-50. This research was presented in part at the 47th Annual Meeting of the American Diabetes Association, Indianapolis, IN, June 6–9, 1987.

{dagger} Recipient of a fellowship grant from the American Physicians Fellowship program.

Received May 6, 1988.




This article has been cited by other articles:


Home page
DiabetesHome page
I. Gabriely and H. Shamoon
Fructose Normalizes Specific Counterregulatory Responses to Hypoglycemia in Patients With Type 1 Diabetes
Diabetes, March 1, 2005; 54(3): 609 - 616.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
P. Galassetti, D. Tate, R. A. Neill, S. Morrey, D. H. Wasserman, and S. N. Davis
Effect of Antecedent Hypoglycemia on Counterregulatory Responses to Subsequent Euglycemic Exercise in Type 1 Diabetes
Diabetes, July 1, 2003; 52(7): 1761 - 1769.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Hawkins, I. Gabriely, R. Wozniak, K. Reddy, L. Rossetti, and H. Shamoon
Glycemic Control Determines Hepatic and Peripheral Glucose Effectiveness in Type 2 Diabetic Subjects
Diabetes, July 1, 2002; 51(7): 2179 - 2189.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
I. Gabriely, M. Hawkins, C. Vilcu, L. Rossetti, and H. Shamoon
Fructose Amplifies Counterregulatory Responses to Hypoglycemia in Humans
Diabetes, April 1, 2002; 51(4): 893 - 900.
[Abstract] [Full Text] [PDF]


Home page
DiabetesHome page
M. Hawkins, I. Gabriely, R. Wozniak, C. Vilcu, H. Shamoon, and L. Rossetti
Fructose Improves the Ability of Hyperglycemia Per Se to Regulate Glucose Production in Type 2 Diabetes
Diabetes, March 1, 2002; 51(3): 606 - 614.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
I. Gabriely, R. Wozniak, M. Hawkins, and H. Shamoon
Troglitazone Amplifies Counterregulatory Responses to Hypoglycemia in Nondiabetic Subjects
J. Clin. Endocrinol. Metab., February 1, 2001; 86(2): 521 - 528.
[Abstract] [Full Text]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Mevorach, J. Kaplan, C. J. Chang, L. Rossetti, and H. Shamoon
Hormone-independent activation of EGP during hypoglycemia is absent in type 1 diabetes mellitus
Am J Physiol Endocrinol Metab, March 1, 2000; 278(3): E421 - E429.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
S. N. Davis, P. Galassetti, D. H. Wasserman, and D. Tate
Effects of Gender on Neuroendocrine and Metabolic Counterregulatory Responses to Exercise in Normal Man
J. Clin. Endocrinol. Metab., January 1, 2000; 85(1): 224 - 230.
[Abstract] [Full Text]


Home page
Clin. Chem.Home page
B. Eden Engstrom, F. A. Karlsson, and L. Wide
Gender Differences in Diurnal Growth Hormone and Epinephrine Values in Young Adults during Ambulation
Clin. Chem., August 1, 1999; 45(8): 1235 - 1239.
[Abstract] [Full Text] [PDF]


Home page
Clin. Chem.Home page
B. E. Engstrom, F. A. Karlsson, and L. Wide
Marked gender differences in ambulatory morning growth hormone values in young adults
Clin. Chem., June 1, 1998; 44(6): 1289 - 1295.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
A. J. Scheen, O. M. Buxton, M. Jison, O. Van Reeth, R. Leproult, M. L'Hermite-Baleriaux, and E. Van Cauter
Effects of exercise on neuroendocrine secretions and glucose regulation at different times of day
Am J Physiol Endocrinol Metab, June 1, 1998; 274(6): E1040 - E1049.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society